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ABSTRACT 
 
Objective 
Glucose dysregulation is an independent risk factor for cardiovascular and neurodegenerative 
disease development through synaptic dysfunction resulting in cognitive decline. The aim of 
this study was to study the interplay between impaired glycemic metabolism (hyperglycemia 
and insulin resistance (IR)), cardiac stress (cardiac troponin T (cTnT) and N-terminal brain 
natriuretic peptide (NT-proBNP)) and executive cognitive function prospectively, in a bi-
ethnic sex cohort. 
Methods 
Black and White teachers (N=338, aged 20-63 years) from the Sympathetic Activity and 
Ambulatory Blood Pressure in Africans study were monitored over a three-year period. 
Fasting blood samples were obtained for cTnT, NT-proBNP, glycated hemoglobin (HbA1c) 
and the homeostatic model assessment (HOMA-IR) for insulin resistance. The STROOP 
colour-word conflict test (STROOP-CWT) was applied to assess executive cognitive function 
at baseline. 
Results 
Over the three-year period Black men revealed constant high levels of cTnT (≥4.2ng/L), pre-
diabetes (HbA1c>5.7%) and IR (HOMA-IR>3). HbA1c was associated with IR (p<0.001) 
and increases in ΔNT-proBNP (p=0.02) in Black men only. In the latter, baseline STROOP-
CWT was inversely associated with cTnT (p=0.001) and IR levels (p=0.01). 
Conclusion 
Progressive myocyte stretch and chronic myocyte injury, coupled with glucose dysregulation 
may interfere with processes related to interference control in Black men. 
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INTRODUCTION 
The importance of blood glucose regulation in cardiovascular disease (CVD) prevention has 
been emphasized.1 Hyperglycemia persists during conditions of chronic stress and vascular 
injury.2,3 One of the causes of hyperglycemia, insulin resistance (IR), plays a detrimental role 
in CVD, as it independently predicts prevalent and incident CVD development.4 Further, 
studies also show that chronic hyperglycemia (glycosylated hemoglobin (HbA1c) ≥5.6)) is 
associated with subclinical myocyte injury.5  
 
Injury to cardiac myocytes has been identified as a major contributing factor for cardiac 
dysfunction and –failure.6 Myocyte injury is the main stimulus for the release of cardiac 
troponin T (cTnT) from the myofibrils in cardiac muscle.7 An association between cTnT and 
N-terminal pro-B-type natriuretic peptide (NT-proBNP) was reported in individuals with the 
metabolic syndrome.8 In Black men from the SABPA cohort, cTnT was also associated with 
NT-proBNP, which may indicate increased cardiac wall strain in our population group.9  
 
There is increasing evidence to suggest a role of cardiac stress in the development of 
neurodegenerative diseases as cTnT and NT-proBNP are independently associated with 
cognitive decline.10,11 Mirza et al., (2015) reported higher NT-proBNP is related to poorer 
performance in multiple cognitive tests (STROOP-colour word conflict test (STROOP-
CWT)) while Gluck et al. (2013) further showed that the STROOP-CWT, was associated 
with impaired glucose regulation.10,12 Furthermore, executive cognitive function, assessed 
with the STROOP-CWT, differed significant between individuals with type 2 diabetes and 
individuals with normal glucose metabolism.13  
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The aim of this study was therefore to study the interplay between impaired glycemic 
metabolism, cardiac- and cognitive function. We assessed the relationship between changes 
(Δ) in cardiac stress risk markers (cTnT and NT-proBNP), glycemic metabolism (HbA1c, IR) 
and a cognitive test score in a bi-ethnic sex cohort over a three-year period. 
 
METHODS 
The Sympathetic and Ambulatory Blood Pressure in Africans (SABPA) prospective cohort 
study included urban Black and Whites teachers from the Dr Kenneth Kaunda Education 
District of the North-West Province of South Africa.14 This selection was chosen to ensure a 
similar socio-economic class.15 From February to May (2008 and 2009), 2170 teachers were 
invited to participate (Figure 1). Participants aged 20-65 years were assessed for eligibility, 
with 407 being included into phase I of the study. Phase II of the study was conducted after a 
period of three years from February to May (2011 and 2012). The successful follow-up rate 
was 87.8% (359 participants; aged 20-63 years). Reasons for non-participation in phase II of 
the study were pregnancy (N=2), death (N=6) and drop outs (N=42). To avoid bias pertaining 
to cardio-metabolic risk, participants with a HIV positive status (N=21) were excluded for the 
purpose of this study.15 Ultimately 338 (152 Black and 186 White) participants remained for 
the present study. 
 
Informed consent was obtained from all the participants prior to the commencement of the 
study. The Ethics Review Board of the North-West University, Potchefstroom Campus 
(NWU-00036-07-S6) gave ethical approval and the study also complied with the Declaration 
of Helsinki’s ethical guidelines, revised in 2008.16 
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Experimental methods and data collection 
All clinical assessments were obtained over 48 hours. Each participant was connected to the 
Cardiotens CE120® (Meditech, Budapest, Hungary) apparatus and accelerometers in order to 
measure 24-hour ambulatory blood pressure (ABPM), electrocardiogram (ECG), as well as 
24-h physical activity. The correct cuff sizes were applied to the non-dominant arm of each 
participant. The participants were transported to the Metabolic Unit Research Facility at the 
North-West University at approximately 16:30 where they were introduced to the 
experimental set-up. Each participant received his/her own private bedroom and a 
standardized dinner. Demographic and General Health questionnaires were also completed. 
The participants were advised to fast and rest from 22:00 for the next day’s clinical 
measurements. 
 
At approximately 07:30 the following morning, the 24-hour ambulatory devices were 
disconnected where after anthropometric and clinical measurements followed. All resting 
ECG’s, blood sampling and STROOP-CWT measures were obtained after the participants 
had been in a semi-recumbent position for approximately 30-45 minutes. Once the 
assessments were completed, the participants received breakfast and were transported back to 
their respective schools. Immediate feedback was also provided. 
 
Lifestyle determinants 
Registered level II anthropometrists obtained the anthropometric measurements according to 
standardized procedures. The mean of three measurements was used to ensure accuracy. 
Inter- and intra-observer variability was found to be less than 10%. The Mosteller formula 
[weight (kg) x height (cm) ÷ 3600]½ was used to calculate the body surface area. The 
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participants’ daily physical activity was also monitored (Actical® activity monitor; Mini 
Mitter Co., Inc., Bend, OR; Montreal, Quebec, Canada).  
 
Biochemical measurements 
Fasting blood samples were obtained by registered nurses from the ante-brachial vein 
utilizing a sterile winged infusion set and handled according to standardized procedures for 
storage at -80°C until analysis. Gamma-glutamyl transferase (γ-GT), an indicator of alcohol 
abuse, were analyzed with the enzyme rate method (Unicel DXC 800; Beckman and Coulter; 
Germany). Serum cotinine, an indicator of nicotine levels, were analyzed with the 
homogeneous immunoassay on Modular ROCHE Automized (Basel, Switzerland). Serum 
cTnT and NT-proBNP were analyzed with the high sensitive electrochemiluminescence 
immunoassay (ECLIA), Elecsys (ROCHE, Basel, Switzerland). In our sample, there were 91 
(26.84%) undetectable cTnT values (<3 pg/ml) that were substituted for lower than detectable 
values. The inter- and intra-batch variability was 15% and 5.6% respectively for cTnT, and 
4.6% and 4.2% for NT-proBNP. An ultra-high-sensitivity turbidimetric method (Unicel DXC 
800, Beckman and Coulter, Germany) was used to analyze C-reactive protein. Serum tumor 
necrosis factor-alpha (TNF-α), was analyzed with the Quantikine High Sensitivity Human 
TNF-α Enzyme linked immunosorbent assay (HS ELISA; R&D Systems, Minneapolis, MN 
USA). Despite serum handling within 30 minutes, the inter- and intra-assay variability for 
TNF-α was 15% and 17.8% respectively. 
 
Fasting blood glucose samples were collected in sodium fluoride tubes and analyzed with the 
timed-end-point method (Unicel DXC 800, Beckman Coulter, Germany). The turbidometric 
inhibition immunoassay was used to determine HbA1c (Integra 400; Roche, Basil, 
Switzerland). Serum insulin was analyzed with the electrochemiluminescence immunoassay 
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(ECLIA; Elecsys 2010, Roche, Basel, Switzerland) with an intra-assay- and inter-assay 
precision of 2% and 2.8% respectively. The homeostatic model assessment (HOMA) was 
used to indicate insulin resistance (IR) and was measured with the following formula: fasting 
glucose x fasting insulin/405.17  
 
Cardiovascular assessment procedures 
As part of the SABPA study design 24-hour BP was measured at 30-minute intervals from 
08:00 to 22:00 and at 60-minute intervals from 22:00 to 06:00.18 The European Society of 
Cardiology criteria for hypertension were employed [average 24-hour systolic blood pressure 
(SBP) of ≥130mmHg and/or diastolic blood pressure (DBP) of ≥80mmHg].15 The data was 
analyzed with the CardioVisions 1.19 Personal Edition software (Meditech, Budapest, 
Hungary). Participants had to record any abnormalities they experienced throughout the day, 
on a 24-hour diary card. The abnormalities included visual disturbances, headaches, nausea, 
fainting, palpitations and stress. The Norav NHH-1200® ECG (NORAV medical LTD PC 
1200, Israel, Software version 5.030) was used to record the resting 10-lead ECG. 
  
Executive cognitive function 
Executive cognitive function was assessed with the STROOP colour-word conflict test 
(STROOP-CWT). The participants were shown a cardboard containing series’ of five words 
in random orders describing a specific color, but written in different colors. The ink color of a 
given word had to be identified verbally. When participants are faced with the task to name 
the ink color of a word instead of reading the word, an interference is caused by the more 
automated task (reading the color represented by the word).19,20 In order to perform the less 
automated task it is therefore required by the participants to inhibit this interference caused 
by the more automated task.19,20 Participants had to guard against reading the color 
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represented by the word. They were also encouraged to progress as fast as possible within 1 
minute, and were interrupted to correct wrong answers. An interference score (STROOP-
CWT) was calculated that represents the number of correct answers produced during the 
fixed period of 1 minute. A lower score thus represents that the individual found it more 
difficult to inhibit the interference.19 The same two scientists obtained STROOP-CWT scores 
of teachers at baseline. Participants received a monetary incentive according to their 
performance on completion of the task. 
 
Statistical analyses 
Statistical analyses were performed with Statistica version 13 (TIBCO Software Inc., Palo 
Alto, USA, 2018). Normal distributions were computed to reveal symmetrical data. 
Logarithmic transformations were used for variables with skewed distributions. Baseline 
characteristics of the two ethnic groups were determined with independent t-tests. Chi-square 
tests (X2) were used to determine prevalence as well as proportions. Single two-way general 
linear model interaction on main effects (ethnicity x sex) were computed for all 
cardiovascular risk markers, independently of a priori defined covariates.15 Dependent t tests 
were used to calculate differences over time in each ethnic group. Percentage changes over 
time (%Δ) were calculated by using the formula: Δ = (follow-up – baseline)/baseline*100. 
McNemar’s case-control tests were used to demonstrate changes when participants without 
diabetes (negative) at baseline become positive at follow-up; and diabetes-positive people at 
baseline recover to negative at follow-up. Forward stepwise regression analyses determined 
associations between dependent variables (∆cTnT, ∆NT-proBNP, ∆HbA1c, ∆HOMA-IR and 
baseline STROOP-CWT) and independent variables (∆cTnT, ∆NT-proBNP, ∆HOMA-IR and 
baseline STROOP-CWT) and additional covariates (inflammation) in several separate 
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models. For all of the above-mentioned analyses, significant values were noted when adjusted 
R2 ≥ 0.25 and p ≤ 0.05. 
 
RESULTS 
Cross-sectional data analyses 
Table 1 represents the clinical characteristics of the South African bi-ethnic sex cohort at 
baseline. Blacks had higher γGT, HbA1C, insulin and blood pressure values than whites. In 
turn, higher body surface area, physical activity, STROOP-CWT scores and cTnT levels were 
found in the Whites. More Blacks than Whites showed hyperglycemia (HbA1c>5.7%), 
compatible with a pre-diabetic state (62% vs 31%; p<0.001). 
 
Significant interactions with sex were revealed for NT-proBNP [F(1,316), 8.19, p=0.005], 
cTnT [F(1,322), 12.44, p<0.001] and with ethnicity for insulin [F(1,324), 4.40, p=0.04]. 
Furthermore, interactions between ethnicity and sex were revealed for cognitive interference 
[F(1,324), 97.20, p<0.001]; [F(1, 324), 21.73, p<0.001] that motivated further stratification 
into ethnic-sex groups. 
 
Longitudinal data analyses 
A total of 33 participants had incomplete data for the main variables that included HbA1c 
(N=8), HOMA-IR (N=4), cTnT (N=9), NT-proBNP (N=11) and STROOP-CWT (N=1). 
Participants with incomplete data (N=33) were however included in all analyses as their 
exclusion did not change the outcome of the results. 
 
Over the three-year period, insulin and IR decreased whereas NT-proBNP increased in 
Blacks and Whites (Supplementary Table S1). Additionally, Whites revealed decreases in 
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cTnT and resting glucose. In Black men, ∆NT-proBNP increased over the three-year period, 
whereas no significant % changes (∆) were revealed for cTnT, HbA1c and IR (Table 2). In 
Black men, incidence of diabetes changed significantly over the three-year follow-up period 
(%Δ 7.36 [OR 0.1 (0.01, 0.78)], p=0.007). Here, 10 participants developed diabetes over the 
three-year period, with only 1 participant recovering from baseline to follow-up. 
 
Forward stepwise regression analyses determined associations between changes (%Δ) in 
cardiac stress markers (NT-proBNP and cTnT), STROOP-CWT, IR and HbA1c over a three-
year period. No associations were evident in women (of either ethnicity) and in White men; 
therefore, we will only report associations found in Black men as shown in Table 3. In Black 
men, constant high HbA1c (>5.7%) was associated with constant high IR (HOMA-IR>3) 
(Adj R2 0.28, β=0.43; 95% CI 0.22 to 0.64; p<0.001) as well as increases in ΔNT-proBNP 
(Adj R2 0.28, β=0.26; 95% CI 0.05 to 0.48; p=0.02). Also in Black men, baseline STROOP-
CWT score was inversely associated with constant high cTnT (>4.2ng/mL) (Adj R2 0.24, β= -
0.36; 95% CI -0.57 to -0.15; p=0.001) and constant high IR (Adj R2 0.24, β= -0.28; 95% CI -
0.49 to -0.06; p=0.01). 
 
DISCUSSION 
The aim of this study was to determine whether changes in markers of cardiac stress were 
associated with changes in insulin resistance, hyperglycemia and a cognitive test score in a 
bi-ethnic male and female cohort. Over a three-year period cardiac stress (NT-proBNP and 
cTnT) associated with dysregulated glucose metabolism (IR and hyperglycemia) may 
interfere with the ability to inhibit cognitive interference. 
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Executive cognitive function, cardiomyocyte injury and glucose metabolism 
In this study, Blacks revealed a lower STROOP-CWT score than Whites indicating that 
Blacks had more difficulty to inhibit cognitive interference than Whites. One of many reasons 
why Blacks revealed lower STROOP-CWT scores than Whites might be explained by the 
inverse association found between STROOP-CWT with constant high (≥4.2ng/L) cTnT 
levels21 in this study, as higher cTnT might lead to subclinical cerebral injury expressed as 
silent brain infarcts and white matter lesions on magnetic resonance imaging.22 Wijsman et 
al., reported that participants with higher hs-cTnT levels had steeper STROOP-CWT declines 
over a period of 3.2 years.23 Indeed, in Black men high levels of cTnT >4.2ng/L indicative of 
ischemic heart disease risk24 was sustained that associated with reduced cardiac output25 
possibly leading to cerebral hypoperfusion resulting in executive functional decline.21  
 
Other factors may also influence cognitive interference scores such as neural activation26 
rather than increased cerebral perfusion in low-level alcohol users when compared to non-
users.27 As alcohol use increases, the difficulty score pertaining to the STROOP-CWT 
increases28 indicating that high levels of alcohol abuse29 and neural activity23 previously 
described in the Black cohort should be considered for the lower cognitive interference scores 
evident in the Blacks. 
 
Cognitive interference was also inversely associated with IR in the current Black male cohort. 
Studies have shown IR to be associated with memory impairments and atrophy of brain 
regions leading to cognitive deficits.30 Usually atrophy of these brain regions occur in early 
onset Alzheimer’s disease (AD).30 Indeed, individuals with diagnosed AD showed reduced 
resistance to cognitive interference31 and hypo-activation of brain areas involved in this 
inhibitory control.32 The exact mechanism of how peripheral IR affects cognitive inhibitory 
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control is however unclear. Numerous mechanisms leading to impaired cognition may apply 
including excessive amyloid beta accumulation and tau hyper-phosphorylation.33 Therefore, 
regulation of blood glucose and correction of IR in clinical setting may be of crucial 
importance for improved cognitive control and health. 
  
Dysregulated glucose and myocyte stretch 
IR has been reported in Black women of South Africa before.34 We expand current findings 
by showing moderate IR (HOMA-IR >3, <5)35 also in Black men. Different cellular 
mechanisms may be involved in the pathogenesis of IR that includes inflammation.36 The 
Insulin Resistance Atherosclerosis Study reported associations between the inflammatory 
marker, TNF-α with higher glucose levels and IR.37 However, statistical adjustments of TNF-
α in our study indicated that moderate IR was evident in Black men, independent of 
inflammation.  
 
The association found between hyperglycemia and IR in our Black male/female cohort may 
underscore their pre-diabetic state (HbA1c >5.7%)35 previously reported by Lammertyn et al., 
(2011).38 Insulin is responsible for the regulation of metabolism as it promotes glycogen 
synthesis and glucose uptake into the cells while inhibiting glucose release into the 
circulation.36 With IR, the tissues thus show reduced sensitivity to insulin-mediated 
biological activity.36 This results in a disrupted balance between glucose uptake and release 
into the circulation leading to excessive glucose accumulation in blood vessels.2,3 
 
Again increased neural activity or depressed heart rate variability in the SABPA Black 
cohort, particularly men23,39 might be one mechanism to explain the chronic hyperglycemia. 
Indeed, non-dipping Black men revealed higher HbA1c values, and associations were 
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demonstrated between chronically elevated blood glucose and a blunted nocturnal blood 
pressure dipping.38 The latter is indicative of autonomic dysfunction and volume overload.40 
NT-proBNP is a valuable marker to assess volume overload as it is released in response to 
myocyte stretch along with BNP that may lead to sympathetic nervous system inhibition, as 
well as the induction of natriuresis and diuresis.41 In this study, we saw that constant elevated 
cTnT and HbA1c levels were associated with NT-proBNP increases. Other studies reported 
an association between chronic hyperglycemia and subclinical myocardial injury, as indicated 
by increased cTnT levels.5 We cautiously suggest that progressive increases in NT-proBNP 
may act as compensatory protective mechanism against chronic hyperglycemia and 
cardiomyocyte injury in the current Black male cohort over a three-year period.  
 
Limitations and Conclusion 
Although this study is the first to represent associations between cardiac stress, 
hyperglycemia, IR and cognitive interference in Blacks, there are limitations. The results 
cannot be attributed to the African population at large as participants consisted of a small 
prospective cohort in South Africa. We did not perform a mechanistic study, so even 
plausible inferences about the interplay of discussed relationships must remain speculative. 
The clinical relevance of our findings needs to be shown beyond a three-year observation 
period.  
 
In conclusion, as depicted in Figure 2, we propose that progression of mycoyte stretch is 
associated with chronic myocyte injury and hyperglycemia in Black men. Furthermore, 
hyperglycemia is associated with insulin resistance that may interfere with the inhibition of 
cognitive interference in these men. Therefore in Black men, progressive myocyte stretch and 
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chronic myocyte injury, coupled with dysregulation of glucose metabolism may interfere 
processes related to interference control. 
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FIGURE LEGENDS 
Figure 1: A South African bi-ethnic sex cohort. 
 
Figure 2: Proposed mechanism of cardiac stress markers and glucose dysregulation 
associating with executive cognitive function in Black men. 
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KEY MESSAGES 
 This longitudinal study is the first to assess the associations between glucose 
dysregulation, myocardial stress and –injury as well as executive cognitive function in a 
South African cohort. 
 In Black men, chronic raised HbA1c levels associated with NT-proBNP upregulation 
and moderate insulin resistance over a three-year period. 
 Executive cognitive function also inversely associated with moderate insulin resistance 
and chronic raised cTnT levels in Black men. 
 Progressive myocyte stretch and chronic myocyte injury, coupled with glucose 
dysregulation may interfere with processes related to interference control in Black men. 
Table 1: Clinical characteristics of a South African bi-ethnic sex cohort at baseline. 
Variables 
Africans  
(N=152) 
Caucasians  
(N=186) 
p-values 
Confounders    
Age, years 44.65 ± 8.13 46.58 ± 9.87  0.053 
Body surface area, m2 1.92 ± 0.22  2.01 ± 0.29 0.001 
TEE, kcal/day 2678.06 ± 814.21 3155.06 ± 1672.30 0.002 
Cotinine, ng/Ml 26.71 ± 60.86 24.05 ± 81.01 0.739 
γGT, U/L 65.74 ± 82.48 28.02 ± 38.28 <0.001 
Potential diabetes risk markers   
Glucose, mmol/L 5.71 ± 2.17 5.71 ± 0.83 0.976 
HbA1C, % 6.08 ± 1.19 5.53 ± 0.43 <0.001 
Insulin, uU/mL 14.96 ± 10.35 12.26 ± 8.70 0.010 
HOMA-IR 3.87 ± 3.26 3.29 ± 2.90 0.083 
Cognition    
STROOP-CWT score 48 ± 11 63 ± 13 <0.001 
Cardiovascular characteristics    
24h SBP, mmHg 132 ± 17 125 ± 12 <0.001 
24h DBP, mmHg 83 ± 11 77 ± 8 <0.001 
NT-proBNP, pg/mL 43.50 ± 45.59 46.35 ± 47.03 0.580 
cTnT, pg/mL 4.90 ± 2.81 5.68 ± 3.60 0.031 
C-reactive protein, mg/L    
TNF-alpha, pg/mL    
Hyperglycemic, N (%) 93 (62.00) 57 (30.65) <0.001 
Moderate IR, N (%) 71 (47.33) 76 (41.08) 0.252 
Medication usage    
Hypertension, N (%) 45 (35.43) 23 (13.45) 0.200 
Anti-diabetic, N (%) 9 (0.07) 8 (0.05) 0.358 
Data are presented as mean ± SD, median (95% CI) or number of participants (%). 
Abbreviations: γGT, Gamma glutamyl transferase; TEE, total energy expenditure; HbA1C, 
glycated hemoglobin; HOMA-IR, Homeostatic model assessment-Insulin resistance; 
STROOP-CWT, STROOP-colour-word conflict test score; SBP, systolic blood pressure; 
DBP, diastolic blood pressure; NT-proBNP, N-terminal pro-b-type-natriuretic peptide; cTnT, 
cardiac troponin T; TNF-alpha, tumor necrosis factor alpha. Hyperglycemic defined as 
HbA1c>5.7% and moderate insulin resistance defined as HOMA-IR>3 (33). 
 
Table 2: Unadjusted differences over a period of 3-years in Black men. 
 Black men (N=77) 
Variables Baseline; Follow-up Difference p-value 
Glucose, mmol/L 6.13; 6.07  -0.07 0.727 
Insulin, uU/mL 15.69; 13.41  -2.28 0.086 
HOMA-IR 4.38; 3.59  -0.79 0.074 
HbA1C, % 6.27; 6.31  +0.04 0.784 
cTnT, pg/mL  5.59; 5.36 -0.23 0.570 
NT-proBNP, pg/mL 36.12; 49.13 +13.01 0.039 
†Diabetes:  
% ∆ [OR (95% CI)], p 
7.36 [0.1 (0.01, 0.78)], 0.007 
†Diabetes  
(BL +, FU -) / (BL -, FU +)  
1 / 10 
Data presented is unadjusted dependent sample T-tests. Abbreviations: HOMA-IR, 
Homeostatic model assessment-Insulin resistance; HbA1C, glycated haemoglobin; cTnT, 
Troponin T; NT-proBNP, N-terminal pro-Brain natriuretic peptide. †McNemar chi-square 
equation values are presented as percentage difference over three years’ time followed by the 
Odds Ratio (±95% Confidence Interval). (BL +, FU -), frequency at baseline positive but 
negative at follow-up; (BL -, FU +), frequency at baseline negative but positive at follow-up. 
 
Table 3: Independent associations between cardiac stress markers, insulin resistance and cognitive 
interference scores on in a Black male cohort. 
 Black men (N=77) 
 ΔNTproBNP ΔcTnT STROOP-
CWT 
ΔHOMA-IR ΔHbA1C 
 β (95%CI) β (95%CI) β (95%CI) β (95%CI)  
Adjusted R2 0.11 0.25 0.24 0.10 0.28 
ΔNTproBNP - 0.31** 
(0.10; 0.52) 
NS NS 0.26* 
(0.05; 0.48) 
ΔcTnT 0.30** 
(0.07; 0.52) 
- -0.36** 
(-0.57; -0.15) 
NS NS 
STROOP-CWT NS -0.32** 
(-0.53; -0.11) 
- -0.26* 
(-0.50; -0.02)  
NS 
ΔHOMA-IR NS NS -0.28* 
(-0.49; -0.06) 
- 0.43† 
(0.22; 0.64) 
Data presented is adjusted for a priori covariates and tumor necrosis factor-alpha. Abbreviations: NT-
proBNP, N-terminal pro-b-type-natriuretic peptide; cTnT, cardiac troponin T; STROOP-CWT, STROOP 
colour-word conflict test score at baseline; HOMA IR, Homeostatic model assessment-Insulin resistance; 
HbA1C, glycated haemoglobin. Superscript symbol shows the trend of significance:*p ≤ 0.05; **p ≤ 0.01; 
†p ≤ 0.001. 
. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: A South African bi-ethnic sex cohort. 
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Figure 2: Proposed mechanism of cardiac stress markers and glucose dysregulation 
associating with executive cognitive function in Black men. Abbreviations: cTnT, cardiac 
troponin T; NT-proBNP, N-terminal pro-B-type natriuretic peptide;  Arrows indicate 
that one variable leads to an increase of the next variable;          Arrows indicate that positive 
associations exist between these variables;          Arrows indicate that one variable may lead 
to a decrease of the next variable. 
NT-proBNP cTnT 
Autonomic 
dysfunction 
Hyperglycaemia IR 
Executive cognitive 
function 
Supplementary Table S1: Unadjusted differences over a period of 3-years in a Black and a White cohort. 
 Blacks (N=152) Whites (N=186) 
Variables Baseline; Follow-up Difference p-value Baseline; Follow-up Difference p-value 
Glucose, mmol/L 5.71; 5.62  -0.09 0.523 5.71; 4.43  -1.28 <0.001 
HbA1C, % 6.07; 6.18  +0.11 0.204 5.53; 5.59 +0.05 0.120 
Insulin, uU/mL 14.80; 12.19  -2.60 <0.001 12.26; 10.32  -1.94 <0.001 
HOMA IR 3.83; 3.08  -0.75 0.004 3.29; 2.16 -1.13 <0.001 
NT-proBNP, pg/mL 43.57; 57.67 +14.11 0.003 46.50; 83.29 +36.79 <0.001 
cTnT, pg/mL  4.89; 4.62 -0.27 0.352 5.47; 4.89 -0.58 <0.001 
Data presented is unadjusted dependent sample T-tests. Abbreviations: HbA1C, glycated hemoglobin; HOMA IR, Homeostatic model 
assessment-Insulin resistance; NT-proBNP, N-terminal pro-b-type-natriuretic peptide; cTnT, cardiac troponin T. 
